Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)

<div>52-year-old woman. Invasive ductal carcinoma with pathologic complete response. Focal asymmetry is detected in the upper outer quadrant of the right breast (a). Contrast-enhanced mammography (b) and magnetic resonance imaging (c) without detectable lesions.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI) 

Figure 5 | Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI) 